ArticleJAAD international2026
Maternal type 1 diabetes mellitus and atopic dermatitis in offspring: A nationwide cohort study.
Article in JAAD international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Atopic dermatitis (AD) is one of the most common chronic inflammatory skin diseases of childhood and contributes substantially to early-life morbidity. Maternal metabolic and allergic conditions have been linked to offspring atopic disease; however, the effect of maternal type 1 diabetes mellitus (T1DM), a chronic autoimmune condition, on AD risk in offspring has not been well defined. Objectives: To examine the association between maternal T1DM during pregnancy and the prevalence of atopic dermatitis in offspring. Methods: We conducted a nationwide retrospective cohort study using electronic medical records from Clalit Health Services, Israel's largest health maintenance organization. Singleton live births between January 1, 2010, and December 31, 2023, were included, with follow-up through December 31, 2024. Maternal T1DM and offspring AD were identified using International Classification of Diseases, 10th Revision codes. Multivariable logistic regression models were used to estimate associations, adjusting for maternal age, socioeconomic status, smoking status, gestational age, infant sex, delivery mode, ethnicity, allergic rhinitis, and follow-up duration. Results: The cohort included 311,708 mother-child pairs, of whom 1104 (0.35%) were born to mothers with T1DM. Atopic dermatitis was more prevalent among offspring of mothers with T1DM compared with those without T1DM (29% vs 26%). In adjusted analyses, maternal T1DM was associated with increased odds of AD in offspring (odds ratio 1.15; 95% confidence interval 1.00-1.32). Additional independent predictors included male sex, maternal smoking, maternal allergic rhinitis, higher socioeconomic status, and shorter gestational age. Maternal hemoglobin A1c levels >6.5% were not associated with AD prevalence. Conclusions: In this large population-based cohort, maternal T1DM was associated with an increase in the prevalence of AD in offspring. While the magnitude of the effect is small, these findings suggest that maternal autoimmune status may contribute to early-life atopic risk.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.